| First Published on Clinicaltrials.gov: |
9/15/2008 |
| Status: |
Currently Recruiting |
| ClinicalTrials.gov ID: |
NCT00753571 |
| Sponsor: |
Peking University |
| Purpose: |
This study will examine the effectiveness of Cistanche Total Glycosides(CTG) in treating patients with amyotrophic lateral sclerosis (ALS). |
| Phase: |
II |
| Treatment Type: |
Orally available in pill form |
| Trial Type: |
Double Blind, Placebo Control |
| Estimated Enrollment: |
40 |
| Eligibility: |
18 to 65 years. Both Genders. No healthy volunteers. |
| Details: |
Two arm study: active comparator of 1.8g/day (6 capsules) of CTG for 9 months, placebo comparator 6 capsules for 9 months. |
| Collaborator(s): |
|
| Location(s): |
|
| Primary Investigator: |
Dongsheng Fan MD |
| Contact: |
|
| Trial Protocol as Published on Clinicaltrials.gov: |
|
| ALS Forum: |
|